(Q44644314)

5 December 2017

title

Effects of Short-Term Exercise Training on Plasminogen Activator Inhibitor (PAI-1) (English)

1 reference

https://api.crossref.org/works/10.1249/01.MSS.0000093751.82616.F0

Orthopedics and sports medicine

29 March 2024

main subject

1 reference

https://api.crossref.org/works/10.1249/01.MSS.0000093751.82616.F0

29 March 2024

author name string

Norie Yasuda

2

1 reference

5 December 2017

Peter F. Bodary

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600550

29 March 2024

Deidre D. Watson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600550

29 March 2024

Adrienne S. Brown

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600550

29 March 2024

J. Mark Davis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600550

29 March 2024

Russell R. Pate

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600550

29 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14600550

29 March 2024

publication date

1 November 2003

1 reference

full work available at URL

5 December 2017

https://journals.lww.com/10.1249/01.MSS.0000093751.82616.F0

1 reference

https://api.crossref.org/works/10.1249/01.MSS.0000093751.82616.F0

Medicine and Science in Sports and Exercise

29 March 2024

published in

1 reference

5 December 2017

volume

35

1 reference

5 December 2017

issue

11

1 reference

5 December 2017

page(s)

1853-1858

1 reference

Comparison of plasminogen activator inhibitor-1 concentration in insulin-resistant versus insulin-sensitive healthy women.

5 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1249/01.MSS.0000093751.82616.F0

Significant changes in VLDL-triacylglycerol and glucose tolerance in obese subjects following ten days of training

29 March 2024

2

1 reference

https://api.crossref.org/works/10.1249/01.MSS.0000093751.82616.F0

Improvement of insulin sensitivity by short-term exercise training in hypertensive African American women.

29 March 2024

4

1 reference

https://api.crossref.org/works/10.1249/01.MSS.0000093751.82616.F0

Plasminogen activator inhibitor-1 activity is independently related to both insulin sensitivity and serum triglycerides in 70-year-old men.

29 March 2024

5

1 reference

https://api.crossref.org/works/10.1249/01.MSS.0000093751.82616.F0

Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects

29 March 2024

6

1 reference

https://api.crossref.org/works/10.1249/01.MSS.0000093751.82616.F0

Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration

29 March 2024

7

1 reference

https://api.crossref.org/works/10.1249/01.MSS.0000093751.82616.F0

Skeletal muscle dictates the fibrinolytic state after exercise training in overweight men with characteristics of metabolic syndrome

29 March 2024

9

1 reference

https://api.crossref.org/works/10.1249/01.MSS.0000093751.82616.F0

Effect of short-term exercise training on leptin and insulin action.

29 March 2024

10

1 reference

https://api.crossref.org/works/10.1249/01.MSS.0000093751.82616.F0

Generalized equations for predicting body density of men

29 March 2024

11

1 reference

https://api.crossref.org/works/10.1249/01.MSS.0000093751.82616.F0

Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women

29 March 2024

13

1 reference

https://api.crossref.org/works/10.1249/01.MSS.0000093751.82616.F0

Intense nonpharmacological intervention in subjects with multiple cardiovascular risk factors: decreased fasting insulin levels but only a minor effect on plasma plasminogen activator inhibitor activity.

29 March 2024

15

1 reference

https://api.crossref.org/works/10.1249/01.MSS.0000093751.82616.F0

Improved fibrinolysis by intense lifestyle intervention. A randomized trial in subjects with impaired glucose tolerance.

29 March 2024

16

1 reference

https://api.crossref.org/works/10.1249/01.MSS.0000093751.82616.F0

Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss

29 March 2024

17

1 reference

https://api.crossref.org/works/10.1249/01.MSS.0000093751.82616.F0

Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women

29 March 2024

18

1 reference

https://api.crossref.org/works/10.1249/01.MSS.0000093751.82616.F0

Physical activity in the prevention and treatment of a thrombogenic profile in the obese: current evidence and research issues

29 March 2024

19

1 reference

https://api.crossref.org/works/10.1249/01.MSS.0000093751.82616.F0

Effects of ageing and regular aerobic exercise on endothelial fibrinolytic capacity in humans

29 March 2024

21

1 reference

https://api.crossref.org/works/10.1249/01.MSS.0000093751.82616.F0

Plasminogen activator inhibitor-1, tissue-type plasminogen activator, and fibrinogen: Effect of dieting with or without exercise in overweight postmenopausal women.

29 March 2024

22

1 reference

https://api.crossref.org/works/10.1249/01.MSS.0000093751.82616.F0

Effects of maximal exercise and venous occlusion on fibrinolytic activity in physically active and inactive men

29 March 2024

23

1 reference

https://api.crossref.org/works/10.1249/01.MSS.0000093751.82616.F0

High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

29 March 2024

24

1 reference

https://api.crossref.org/works/10.1249/01.MSS.0000093751.82616.F0

29 March 2024

Identifiers

1 reference

5 December 2017

1 reference